Met Life Investment Management, LLC Axogen, Inc. Transaction History
Met Life Investment Management, LLC
- $18 Billion
- Q4 2024
A detailed history of Met Life Investment Management, LLC transactions in Axogen, Inc. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 26,034 shares of AXGN stock, worth $453,512. This represents 0.0% of its overall portfolio holdings.
Number of Shares
26,034
Previous 23,715
9.78%
Holding current value
$453,512
Previous $332,000
29.22%
% of portfolio
0.0%
Previous 0.0%
Shares
36 transactions
Others Institutions Holding AXGN
# of Institutions
179Shares Held
36.2MCall Options Held
82.6KPut Options Held
1.1K-
First Light Asset Management, LLC Edina, MN4.51MShares$78.5 Million7.26% of portfolio
-
Black Rock Inc. New York, NY3.25MShares$56.6 Million0.0% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT2.96MShares$51.5 Million3.39% of portfolio
-
Morgan Stanley New York, NY2.43MShares$42.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.43MShares$42.3 Million0.0% of portfolio
About Axogen, Inc.
- Ticker AXGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 42,283,700
- Market Cap $737M
- Description
- AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...